In vascular beds, a potent vasoconstrictor of endothelin-1 (ET-1) is p
roduced by endothelial cells and released preferentially to the basal
side of endothelial cells. It acts on endothelial cells and on the und
erlying smooth muscle cells, as a modulator of vascular tone, in an au
tocrine and paracine manner. ET-1 induces release of relaxing factors
(nitric oxide and prostacycline) from endothelial cells. Whether relax
ation or constriction is predominantly elicited by endogenous ET-I may
depend on the concentration of ET-1 in vascular beds, the density and
mode of distribution of ET receptor subtypes on the endothelial and s
mooth muscle cells, the turnover of the receptors, and the existing co
nditions of each vascular beds. When ET-1 is overproduced by endotheli
al cells at pathological conditions, endogenous ET-1 acts as a vasocon
strictor. However, ET-1 may act as a vasodilator at physiologically lo
w concentrations, depending on the existing condition.